- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x SY9: STRYCHNINE(Non-covalent)
- 31 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 9 residues within 4Å:- Chain A: V.118, L.119
- Chain E: T.108, A.109, S.112, R.114, P.115, V.116
- Ligands: NA.42
Ligand excluded by PLIPEDO.3: 7 residues within 4Å:- Chain A: M.36, Y.37, L.79, S.81, L.82, I.102, W.103
Ligand excluded by PLIPEDO.4: 5 residues within 4Å:- Chain A: V.118, Q.122, F.134, P.136, Q.138
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: Q.179, V.180, L.182, S.195, A.196, T.197
Ligand excluded by PLIPEDO.8: 10 residues within 4Å:- Chain A: T.108, A.109, S.112, R.114, P.115, V.116
- Chain B: V.118, L.119
- Ligands: NA.6, ACT.7
Ligand excluded by PLIPEDO.9: 9 residues within 4Å:- Chain A: P.38, P.40, T.41, Y.166, E.170
- Chain B: L.23, D.94, F.95, R.96
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: R.74, V.125, M.133, S.135
- Ligands: ACT.10, SY9.45
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain B: W.103, Y.166
- Chain C: T.97, S.98, I.123
Ligand excluded by PLIPEDO.15: 8 residues within 4Å:- Chain B: M.36, Y.37, L.79, S.81, L.82, I.102, W.103
- Ligands: EDO.17
Ligand excluded by PLIPEDO.16: 3 residues within 4Å:- Chain B: Q.179, S.195, A.196
Ligand excluded by PLIPEDO.17: 9 residues within 4Å:- Chain B: S.34, P.35, M.36, Y.37, P.38, S.81
- Chain C: Q.20, M.24
- Ligands: EDO.15
Ligand excluded by PLIPEDO.20: 10 residues within 4Å:- Chain B: T.108, A.109, S.112, R.114, P.115, V.116
- Chain C: V.118, L.119
- Ligands: NA.18, ACT.19
Ligand excluded by PLIPEDO.21: 9 residues within 4Å:- Chain B: P.38, P.40, T.41, Y.166, E.170
- Chain C: L.23, D.94, F.95, R.96
Ligand excluded by PLIPEDO.23: 6 residues within 4Å:- Chain B: V.165
- Chain C: R.96, V.125, M.133
- Ligands: SY9.12, ACT.22
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain C: W.103, Y.166
- Chain D: S.98
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain C: Y.37, L.79, S.81, L.82, I.102, W.103
Ligand excluded by PLIPEDO.28: 7 residues within 4Å:- Chain C: N.65, D.145, T.147
- Chain D: S.188, S.189, K.190, R.224
Ligand excluded by PLIPEDO.29: 5 residues within 4Å:- Chain B: S.111, M.143
- Chain C: Q.55, S.184, Y.186
Ligand excluded by PLIPEDO.32: 9 residues within 4Å:- Chain C: T.108, A.109, S.112, R.114, P.115, V.116
- Chain D: V.118, L.119
- Ligands: NA.30
Ligand excluded by PLIPEDO.36: 7 residues within 4Å:- Chain D: Y.37, L.79, S.81, L.82, I.102, W.103
- Ligands: EDO.40
Ligand excluded by PLIPEDO.37: 5 residues within 4Å:- Chain D: Y.37, L.79, N.80, S.81
- Chain E: Q.20
Ligand excluded by PLIPEDO.38: 8 residues within 4Å:- Chain C: P.38, P.40, Y.166, E.170
- Chain D: L.23, D.94, F.95, R.96
Ligand excluded by PLIPEDO.39: 6 residues within 4Å:- Chain D: N.65, D.145, T.147
- Chain E: S.188, S.189, R.224
Ligand excluded by PLIPEDO.40: 6 residues within 4Å:- Chain D: L.30, F.31, S.34, P.35, M.36
- Ligands: EDO.36
Ligand excluded by PLIPEDO.44: 5 residues within 4Å:- Chain E: R.74, V.125, M.133
- Ligands: SY9.33, ACT.35
Ligand excluded by PLIPEDO.49: 9 residues within 4Å:- Chain D: T.108, A.109, S.112, R.114, P.115, V.116
- Chain E: V.118, L.119
- Ligands: NA.41
Ligand excluded by PLIPEDO.50: 6 residues within 4Å:- Chain A: R.96, T.97, S.98
- Chain E: P.38, W.103, Y.166
Ligand excluded by PLIPEDO.51: 5 residues within 4Å:- Chain A: Q.20
- Chain E: Y.37, L.79, N.80, S.81
Ligand excluded by PLIPEDO.52: 7 residues within 4Å:- Chain A: S.188, S.189, K.190, R.224
- Chain E: N.65, D.145, T.147
Ligand excluded by PLIPEDO.53: 5 residues within 4Å:- Chain D: S.111, M.143
- Chain E: Q.55, S.184, Y.186
Ligand excluded by PLIPEDO.54: 7 residues within 4Å:- Chain E: M.36, Y.37, L.79, S.81, L.82, I.102, W.103
Ligand excluded by PLIP- 5 x NA: SODIUM ION(Non-functional Binders)
NA.6: 6 residues within 4Å:- Chain A: T.108, A.109, S.112
- Chain B: L.119
- Ligands: ACT.7, EDO.8
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.112, A:S.112
NA.18: 6 residues within 4Å:- Chain B: T.108, A.109, S.112
- Chain C: L.119
- Ligands: ACT.19, EDO.20
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:A.109
NA.30: 6 residues within 4Å:- Chain C: T.108, A.109, S.112
- Chain D: L.119
- Ligands: ACT.31, EDO.32
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:L.119
NA.41: 6 residues within 4Å:- Chain D: T.108, A.109, S.112
- Chain E: L.119
- Ligands: ACT.47, EDO.49
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:A.109
NA.42: 6 residues within 4Å:- Chain A: L.119
- Chain E: T.108, A.109, S.112
- Ligands: EDO.2, ACT.43
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain E- Hydrogen bonds: A:L.119
- Water bridges: E:T.108
- 9 x ACT: ACETATE ION(Non-functional Binders)
ACT.7: 11 residues within 4Å:- Chain A: A.109, A.110, S.111, S.112, M.143
- Chain B: Q.55, V.70, L.119, A.137
- Ligands: NA.6, EDO.8
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:S.112, A:S.112, B:Q.55
- Water bridges: A:T.108
- Hydrophobic interactions: B:V.70
ACT.10: 5 residues within 4Å:- Chain A: S.135
- Chain E: W.164, V.165
- Ligands: EDO.11, SY9.45
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain A- Hydrogen bonds: E:W.164
- Water bridges: A:S.135, A:S.135
ACT.19: 10 residues within 4Å:- Chain B: A.109, A.110, S.111, S.112
- Chain C: Q.55, V.70, L.119, A.137
- Ligands: NA.18, EDO.20
6 PLIP interactions:3 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:V.70, C:L.119
- Hydrogen bonds: C:Q.55, B:S.112, B:S.112
- Water bridges: B:T.108
ACT.22: 5 residues within 4Å:- Chain B: W.164, V.165
- Chain C: S.135
- Ligands: SY9.12, EDO.23
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:V.165
- Hydrogen bonds: B:W.164
- Water bridges: C:S.135
ACT.31: 9 residues within 4Å:- Chain C: A.109, A.110, S.111, S.112
- Chain D: Q.55, V.70, L.119, A.137
- Ligands: NA.30
4 PLIP interactions:1 interactions with chain C, 3 interactions with chain D- Hydrogen bonds: C:S.112, D:Q.55, D:Q.55
- Hydrophobic interactions: D:V.70
ACT.35: 6 residues within 4Å:- Chain D: W.164, V.165
- Chain E: M.133, S.135
- Ligands: SY9.33, EDO.44
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain D- Hydrogen bonds: E:S.135, D:W.164
ACT.43: 10 residues within 4Å:- Chain A: Q.55, V.70, L.119, A.137
- Chain E: A.109, A.110, S.111, S.112, M.143
- Ligands: NA.42
6 PLIP interactions:3 interactions with chain A, 3 interactions with chain E- Hydrophobic interactions: A:V.70, A:L.119
- Hydrogen bonds: A:Q.55, E:S.112, E:S.112
- Water bridges: E:T.108
ACT.47: 9 residues within 4Å:- Chain D: A.109, A.110, S.111, S.112
- Chain E: Q.55, V.70, L.119, A.137
- Ligands: NA.41
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain E- Hydrogen bonds: D:S.112, E:Q.55, E:Q.55
- Water bridges: D:T.108
- Hydrophobic interactions: E:V.70
ACT.48: 3 residues within 4Å:- Chain E: P.45, T.47, G.168
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:P.45
- Hydrogen bonds: E:T.47
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 2 residues within 4Å:- Chain B: N.87, N.91
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.87
NAG.25: 3 residues within 4Å:- Chain B: D.43
- Chain C: G.90, N.91
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.91
NAG.34: 1 residues within 4Å:- Chain D: N.91
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.91
NAG.46: 1 residues within 4Å:- Chain E: N.91
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.91
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dawson, A. et al., Engineering a surrogate human heteromeric alpha / beta glycine receptor orthosteric site exploiting the structural homology and stability of acetylcholine-binding protein. Iucrj (2019)
- Release Date
- 2018-08-01
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x SY9: STRYCHNINE(Non-covalent)
- 31 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 5 x NA: SODIUM ION(Non-functional Binders)
- 9 x ACT: ACETATE ION(Non-functional Binders)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dawson, A. et al., Engineering a surrogate human heteromeric alpha / beta glycine receptor orthosteric site exploiting the structural homology and stability of acetylcholine-binding protein. Iucrj (2019)
- Release Date
- 2018-08-01
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E